Patents by Inventor Gopal Potti

Gopal Potti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10272039
    Abstract: A sodium nitrite formulation for topical administration is described. The formulation includes an aqueous solution of non-acidified sodium nitrite dispersed in a white petrolatum ointment. The concentration of sodium nitrite in the formulation is about 0.5% to about 3.0% by weight. To prepare the formulation, non-acidified sodium nitrite is completely dissolved in a small quantity of water, sterile filtered and dispersed in white petrolatum ointment.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: April 30, 2019
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Haksong Jin, George Grimes, Deborah Sperling, Gopal Potti, Caterina P. Minniti, Gregory J. Kato
  • Publication number: 20170333345
    Abstract: A sodium nitrite formulation for topical administration is described. The formulation includes an aqueous solution of non-acidified sodium nitrite dispersed in a white petrolatum ointment. The concentration of sodium nitrite in the formulation is about 0.5% to about 3.0% by weight. To prepare the formulation, non-acidified sodium nitrite is completely dissolved in a small quantity of water, sterile filtered and dispersed in white petrolatum ointment.
    Type: Application
    Filed: November 10, 2015
    Publication date: November 23, 2017
    Applicant: The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Haksong Jin, George Grimes, Deborah Sperling, Gopal Potti, Caterina P. Minniti, Gregory J. Kato
  • Publication number: 20080008762
    Abstract: The invention provides steroid-containing pharmaceutical compositions which are free of classical preservatives and preferably comprise a steroid that is sparingly soluble or substantially insoluble in water, particulate steroid having an average particle size of from about 2.2 to about 10 microns. The pharmaceutical compositions can be used to treat medical conditions, including ophthalmological and back pain conditions.
    Type: Application
    Filed: November 17, 2005
    Publication date: January 10, 2008
    Applicant: Government of the US, as represented by the Secretary, Department of Health and Human Services
    Inventors: Michael Robinson, George Grimes, Luisa Gravlin, Gopal Potti, Peng Yuan, Karl Csaky